DEXCOM INC Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2010 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Dexcom Inc quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2010 to Q4 2023.
  • Dexcom Inc Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $264M, a 236% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $264M +$186M +236% Dec 31, 2023 10-K 2024-02-08
Q4 2022 $78.7M +$8.8M +12.6% Dec 31, 2022 10-K 2024-02-08
Q4 2021 $69.9M +$14.4M +25.9% Dec 31, 2021 10-K 2023-02-09
Q4 2020 $55.5M -$277M -83.3% Dec 31, 2020 10-K 2022-02-14
Q4 2019 $332M +$2.1M +0.64% Dec 31, 2019 10-K 2021-02-11
Q4 2018 $330M +$66.6M +25.3% Dec 31, 2018 10-K 2020-02-13
Q4 2017 $264M +$70.1M +36.2% Dec 31, 2017 10-K 2019-02-21
Q4 2016 $193M -$3M -1.53% Dec 31, 2016 10-K 2018-02-27
Q4 2015 $196M +$27.4M +16.2% Dec 31, 2015 10-K 2017-02-28
Q4 2014 $169M +$4.3M +2.61% Dec 31, 2014 10-K 2016-02-23
Q4 2013 $165M +$13.4M +8.86% Dec 31, 2013 10-K 2015-02-25
Q4 2012 $151M +$16.6M +12.3% Dec 31, 2012 10-K 2014-02-20
Q4 2011 $135M +$16.4M +13.9% Dec 31, 2011 10-K 2013-02-21
Q4 2010 $118M Dec 31, 2010 10-K 2012-02-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.